The latest updates on our research and how it is improving people’s lives.
28 September 2023
The early warning signs of psoriatic arthritis (PsA) can be hard to spot. Any delay in diagnosis of PsA can leave patients uncomfortable and in pain. But slow diagnosis is all too common, according to Professor Laura Coates. She is leading a new study called HPOS, that is looking for 2000 UK volunteers to chart their psoriasis symptoms, and which may help to explain why one third of psoriasis patients to go on to develop arthritis.
25 September 2023
Researchers at NDORMS have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
15 September 2023
Three new Oxford-BMS Fellowships were announced across the Medical Sciences Division to support translational research projects.
Professor Chris Lavy named Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow
13 September 2023
NDORMS Professor of Orthopaedic and Tropical Surgery Chris Lavy has been made an Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow.
12 September 2023
Arthrofibrosis is the build-up of too much scar tissue (fibrosis) after an injury or surgery resulting in a stiffening of a joint and causing pain and disability. It’s common following knee replacement for osteoarthritis where 1 in 4 affected patients require additional surgery to correct the fibrosis and restore motion in the knee joint.
Fair safe medical AI: a South Asia case study to co-develop local agency & trust leaving no one behind
11 September 2023
The Planetary Health Informatics Lab led by Associate Professor Sara Khalid at NDORMS has announced that it is a winner of a Global Grand Challenges award – an initiative fostering innovation to solve pressing global health and development problems and funded by the Bill & Melinda Gates Foundation.
4 September 2023
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient’s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
3 August 2023
Research into the onset and progression of diseases affecting musculoskeletal soft tissues could be greatly advanced using novel 3D models say NDORMS researchers in a review published in The Lancet Rheumatology.
6 July 2023
The UK’s first Space Innovation Lab, dedicated to understanding the effect of space microgravity on the ageing process, opens at the Botnar Institute today.
3 July 2023
A new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.
22 June 2023
A large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.
22 June 2023
Patients treated by surgeons who average over 10 shoulder replacements a year have a lower risk of reoperation and serious complications, and a shorter hospital stay than those treated by surgeons who do fewer operations, finds a study published by The BMJ.
9 June 2023
An international group of researchers, including Prof. Daniel Prieto-Alhambra at NDORMS, have predicted that hip fracture burden will nearly double worldwide by 2050
1 June 2023
A team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.